Antiplatelet therapy type Has Minimal Impact on Outcomes After Valve-in-Valve TAVR: Study Dr Riya Dave14 Oct 2025 8:30 PM ISTResearchers have found in a new study that among patients undergoing valve-in-valve transcatheter aortic procedures, antiplatelet therapy type Dual...
Dotinurad Outperforms Febuxostat in Lowering Uric Acid Levels in Chinese Gout Patients: Phase 3 Trial Medha Baranwal14 Oct 2025 8:00 PM ISTChina: A phase 3 clinical trial has shown that dotinurad, a selective urate reabsorption inhibitor, is more effective than febuxostat in reducing...
EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress Deeksha Bhandari14 Oct 2025 12:51 PM ISTEvery 12 minutes, a person with diabetes thinks about their condition. For many, this constant burden leads to diabetes distress-a state of...
PRO-ACT Study Compares Topical Minoxidil 5% with PRCT vs Plain Minoxidil 5% in Androgenetic Alopecia-Combination Shows Superior Efficacy Dr. Garima Soni14 Oct 2025 12:31 PM ISTA Novel formulation of Minoxidil 5% and PRCT (Procapil, Redensyl, Caffeine, and Transcutol) has emerged superior in effectiveness, tolerability, and...
Acupuncture may Improve Glycemic Control in Type 2 Diabetes: Study Jacinthlyn Sylvia14 Oct 2025 9:15 AM ISTA new study published in the Postgraduate Medical Journal showed that acupuncture significantly reduces FBG, HbA1c, 2hPG, and HOMA-IR in patients with...
Marstacimab Shows Promising Efficacy in Hemophilia Management: Study Medha Baranwal14 Oct 2025 8:45 AM ISTCanada: The phase 3 BASIS trial demonstrated that marstacimab, a TFPI-targeting therapy enhancing thrombin generation independently of FVIII and FIX,...
WHO Warns of Growing Global Resistance to Common Antibiotics Dr. Kamal Kant Kohli14 Oct 2025 8:45 AM ISTOne in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments,...
POTS common in patients with long COVID: Study Dr. Kamal Kant Kohli14 Oct 2025 8:30 AM ISTA new study from Karolinska Institutet in Sweden shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID....
Universal Free School Meals Linked to Lower Childhood Blood Pressure: JAMA Dr Riya Dave13 Oct 2025 9:00 PM ISTResearchers have determined in a new study that the implementation of the Community Eligibility Provision (CEP), a federal policy of universal free...
Telitacicept Effectively Reduces Proteinuria in IgA Nephropathy with Safe Tolerability: Study Medha Baranwal13 Oct 2025 9:00 PM ISTChina: Telitacicept significantly reduced proteinuria in patients with IgA nephropathy, while maintaining an acceptable safety profile comparable to...
Targeted Indoor Spraying Shows No Significant Reduction in Aedes-Borne Disease Incidence: NEJM Dr Riya Dave13 Oct 2025 8:45 PM ISTResearchers have found in a new study that targeted indoor residual spraying reduced mosquito levels but did not significantly decrease Aedes-borne...
FDA Expands UZEDY Approval to Bipolar I Disorder Dr. Kamal Kant Kohli13 Oct 2025 8:30 PM ISTParis: The FDA has approved UZEDY, the first subcutaneous long-acting risperidone formulation utilizing SteadyTeq technology, for maintenance...
